<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03830086</url>
  </required_header>
  <id_info>
    <org_study_id>160/2016/O/Oss</org_study_id>
    <nct_id>NCT03830086</nct_id>
  </id_info>
  <brief_title>Regional Anesthesia Versus General Anesthesia</brief_title>
  <official_title>Regional Anesthesia Versus General Anesthesia in Patients Undergoing Laparoscopic Gynecological Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing laparoscopic gynecological surgery will receive regional anesthesia or
      general anesthesia with endotracheal intubation. The investigators aim to evaluate the
      feasibility and safety of regional anesthesia for laparoscopic gynecological procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Commonly, laparoscopic gynecological procedures are performed under general anesthesia with
      endotracheal intubation.

      The use of regional anesthesia in laparoscopy is reserved to patients declared unfit for
      general anesthesia because of severe comorbidities or it is applied in combination with
      general anesthesia to decrease postoperative pain.

      Recently, growing literature evidence supports the use of regional anesthesia in patients
      undergoing laparoscopy.

      The combination of minimally invasive surgery with regional anesthesia could increase the
      advantages of laparoscopic operations (less postoperative pain, shorter hospital stay, etc).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 7, 2019</start_date>
  <completion_date type="Actual">April 30, 2019</completion_date>
  <primary_completion_date type="Actual">April 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility and safety: Clavien-Dindo Classification (from Grade I to V)</measure>
    <time_frame>From the surgery time, assessed up to 7 days after surgery</time_frame>
    <description>Evaluation of feasibility and safety of regional anesthesia for gynecological laparoscopic surgery, considering complications using Clavien-Dindo Classification (from Grade I to V)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea or emesis.</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>evaluation of the presence of postoperative nausea or emesis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of hospitalization</measure>
    <time_frame>From surgery to hospitalization discharge, assessed up to 7 days after surgery.</time_frame>
    <description>Number of days of hospitalization after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Day of mobilization.</measure>
    <time_frame>From surgery to day of first mobilization, assessed up to 7 days after surgery.</time_frame>
    <description>Day of first mobilization after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Day of feeding.</measure>
    <time_frame>From surgery to day of first feeding, assessed up to 7 days after surgery.</time_frame>
    <description>Day of first feeding after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Day of canalization.</measure>
    <time_frame>From surgery to day of first canalization, assessed up to 7 days after surgery.</time_frame>
    <description>Day of first canalization after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative pain: verbal numeric rating scale</measure>
    <time_frame>Intraoperative: from skin incision to cutaneous suture.</time_frame>
    <description>Intraoperative pain in patients submitted to regional anesthesia (Group B), using a verbal numeric rating scale, from 0 to 10, where 0 is no pain and 10 is the worse pain ever</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimum respiratory rate</measure>
    <time_frame>Intraoperative: from skin incision to cutaneous suture.</time_frame>
    <description>Minimum respiratory rate during surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End-Tidal PCO2 before pneumoperitoneum.</measure>
    <time_frame>Intraoperative: from anesthesia to the beginning of pneumoperitoneum induction.</time_frame>
    <description>End-Tidal PCO2 is measured by capnography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End-Tidal PCO2 during pneumoperitoneum.</measure>
    <time_frame>Intraoperative: pneumoperitoneum time expressed in minutes.</time_frame>
    <description>End-Tidal PCO2 is measured by capnography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain: numerical rating scale</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>Evaluation of postoperative pain in patients undergoing general or regional anesthesia for gynecological laparoscopic surgery, measured with verbal numerical rating scale, from 0 to 10, where 0 is no pain and 10 is the worse pain ever</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Group A: general anesthesia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients undergoing gynecological laparoscopic surgery under general anesthesia, using the following drugs: Midazolam, Propofol, Sufentanil, Rocuronium, Sevoflurane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B: regional anesthesia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients undergoing gynecological laparoscopic surgery under regional anesthesia, using the following drugs: Sufentanil, Bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Used for general anesthesia for gynecological laparoscopic procedures, together with Propofol, Sufentanil, Rocuronium, Sevoflurane</description>
    <arm_group_label>Group A: general anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sufentanil</intervention_name>
    <description>Used for regional anesthesia (spinal or combined spinal-epidural anesthesia) for gynecological laparoscopic procedures together with Bupivacaine; and for general anesthesia for gynecological laparoscopic procedures, together with following drugs: Midazolam, Propofol, Rocuronium, Sevoflurane</description>
    <arm_group_label>Group A: general anesthesia</arm_group_label>
    <arm_group_label>Group B: regional anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Used for general anesthesia for gynecological laparoscopic procedures, together with the following drugs: Midazolam, Sufentanil, Rocuronium, Sevoflurane</description>
    <arm_group_label>Group A: general anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <description>Used for general anesthesia for gynecological laparoscopic procedures, together with the following drugs: Midazolam, Propofol, Sufentanil, Sevoflurane</description>
    <arm_group_label>Group A: general anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Used for general anesthesia for gynecological laparoscopic procedures, together with the following drugs: Midazolam, Propofol, Sufentanil, Rocuronium</description>
    <arm_group_label>Group A: general anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Used for regional anesthesia (spinal or combined spinal-epidural anesthesia) for gynecological laparoscopic procedures, together with Sufentanil</description>
    <arm_group_label>Group B: regional anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing gynecological laparoscopic surgery;

          -  expected surgical time shorter than 90 minutes;

          -  informed consent to participate in the study.

        Exclusion Criteria: none.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cardiothoracic and Vascular Anesthesia and Intensive Care, S. OrsolaMalpighi University Hospital</name>
      <address>
        <city>Bologna</city>
        <state>BO</state>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gynecology and Physiopathology of Human Reproductive Unit, University of Bologna, S. Orsola-Malpighi Hospital</name>
      <address>
        <city>Bologna</city>
        <state>BO</state>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>January 12, 2019</study_first_submitted>
  <study_first_submitted_qc>February 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2019</study_first_posted>
  <last_update_submitted>July 12, 2019</last_update_submitted>
  <last_update_submitted_qc>July 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</investigator_affiliation>
    <investigator_full_name>Mohamed Mabrouk</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>postoperative pain</keyword>
  <keyword>regional anesthesia</keyword>
  <keyword>general anesthesia</keyword>
  <keyword>gynecological laparoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

